Characterization of a Novel Multi-Resistant Pseudomonas Juntendi Strain from China with Chromosomal Blavim−2 and a Megaplasmid Coharboring Blaimp−1−like and Blaoxa−1

Shiman Jiang,Yaling Li,Kefan Bi,Sisi Yang,He Xia,Shengjie Li,Hui Chen,Lanjuan Li
DOI: https://doi.org/10.1186/s12864-024-10688-2
IF: 4.547
2024-01-01
BMC Genomics
Abstract:BACKGROUND:Pseudomonas juntendi is a newly identified opportunistic pathogen, of which we have limited understanding. P. juntendi strains are often multidrug resistant, which complicates clinical management of infection. METHODS:A strain of Pseudomonas juntendi (strain L4326) isolated from feces was characterized by MALDI-TOF-MS and Average Nucleotide Identity BLAST. This strain was further subject to whole-genome sequencing and Maximum Likelihood phylogenetic analysis. The strain was phenotypically characterized by antimicrobial susceptibility testing and conjugation assays. RESULTS:We have isolated the novel P. juntendi strain L4236, which was multidrug resistant, but retained sensitivity to amikacin. L4236 harbored a megaplasmid that encoded blaOXA-1 and a novel blaIMP-1 resistance gene variant. P. juntendi strain L4236 was phylogenetically related to P. juntendi strain SAMN30525517. CONCLUSION:A rare P. juntendi strain was isolated from human feces in southern China with a megaplasmid coharboring blaIMP-1-like and blaOXA-1. Antimicrobial selection pressures may have driven acquisition of drug-resistance gene mutations and carriage of the megaplasmid.
What problem does this paper attempt to address?